Craneware plc Total Voting Rights (8323G)
01 April 2022 - 2:09AM
UK Regulatory
TIDMCRW
RNS Number : 8323G
Craneware plc
31 March 2022
Craneware plc
("Craneware" or the "Company" or the "Group")
Total Voting Rights
As at 31 March 2022, the Company's issued share capital
consisted of 35,542,169 ordinary shares of 1 pence each ("Ordinary
Shares") all with voting rights. No shares are currently held in
treasury. The total number of voting rights in the Company as at 31
March 2022 is therefore 35,542,169.
The above figure (35,542,169 Ordinary Shares) may be used by
shareholders as the denominator for the calculation by which they
will determine if they are required to notify their interest in, or
a change in their interest in, the Company.
For further information, please contact:
Craneware plc +44 (0)131 550 3100
Keith Neilson, CEO
Craig Preston, CFO
Alma (Financial PR) +44 (0)20 3405 0205
Caroline Forde, Hilary Buchanan, Joe Pederzolli craneware@almapr.co.uk
Peel Hunt (NOMAD and Joint Broker) +44 (0)20 7418 8900
Dan Webster, Andrew Clark
Investec Bank PLC (Joint Broker) +44 (0)20 7597 5970
Patrick Robb, Henry Reast, Sebastian Lawrence
Berenberg (Joint Broker ) +44 (0)20 3207 7800
Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff
About Craneware
We at the Craneware Group of companies, including our latest
additions Sentry Data Systems and Agilum Healthcare Intelligence,
passionately believe we can impact healthcare profoundly by
delivering the insights healthcare organizations need to also
transform the business of healthcare. Our shared vision is to be
the operational and financial partner for U.S. healthcare
providers.
Our combined suite of applications and industry-leading team of
experts help our customers contextualize operational, financial,
and clinical data, providing insights that clearly demonstrate what
great looks like. These value cycle insights deliver revenue
integrity and 340B compliance, as well as margin and operational
intelligence - something no other single partner can provide.
Together, approximately 40% of registered U.S. hospitals are now
our customers, including more than 2,000 U.S hospitals and health
systems and almost 10,000 clinics and affiliated retail pharmacies.
Our customers are operating with a financial impact of nearly half
a trillion dollars. We have data sets from customers covering more
than 150 million unique patients encounters.
Learn more at www.craneware.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRBKDBKPBKDONN
(END) Dow Jones Newswires
March 31, 2022 11:09 ET (15:09 GMT)
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2024 to May 2024
Craneware (LSE:CRW)
Historical Stock Chart
From May 2023 to May 2024